Healthcare News 7 December 2025

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements,

20 December 2025

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

December 16, 2025 — Johnson & Johnson stock (NYSE: JNJ) is trading lower on Tuesday after pushing to fresh highs earlier this week, as investors weigh a mix of pipeline momentum, legal headlines, and an approaching earnings update that could

16 December 2025

Earnings Reports · Healthcare · Investment Analysis · Pharmaceuticals · Stock Market

Merck Stock (MRK) News Today: BofA Raises Target to $120 as Winrevair Expansion and Dividend Date Spotlight 2026 Outlook

December 15, 2025 — Merck & Co., Inc. (NYSE: MRK) traded around $99.59 in Monday afternoon action, down about 0.23% on the day, as investors balanced a fresh wave of bullish analyst updates against a busy set of catalysts spanning

15 December 2025

Company News · Healthcare · Investment · NYSE:MRK · Pharmaceuticals · Stock Market

Abbott Laboratories (ABT) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Abbott Laboratories (NYSE: ABT) heads into Monday’s session with investors weighing a busy set of headlines—ranging from a fresh dividend hike to a high-profile acquisition in cancer diagnostics, plus regulatory attention around certain FreeStyle Libre sensors. ABT closed Friday, Dec.

15 December 2025

Financial News · Healthcare · Investing · Market Analysis · NYSE:ABT · Stocks

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Updated: December 14, 2025Coverage window for this report: December 8–14, 2025 Wall Street heads into the week of Dec. 15, 2025 with U.S. healthcare and pharma mega-caps back in the spotlight—pulled by three powerful forces that all intensified in the

14 December 2025

Earnings · Healthcare · Industry News · Pharmaceuticals · US Stocks

Canada Stock Market Today: TSX Slips After Record High as Tech Drops, Cannabis Rally Lifts Healthcare (Dec. 12, 2025)

TORONTO (After the Bell, 4:30 p.m. ET) — Canada’s benchmark stock index ended Friday in the red after a choppy session that saw early strength in cannabis and mining shares give way to a broad tech-led pullback. The S&P/TSX Composite Index closed

12 December 2025

Cannabis · Healthcare · NYSE:CLS · Stock Market · Technology · TSX

Molina Healthcare Stock (NYSE: MOH) News on Dec. 12, 2025: Rally Extends as ACA Subsidy Deadline, 2026 Outlook, and Analyst Forecasts Collide

Molina Healthcare, Inc. (NYSE: MOH) stock was trading around $169.53 on Friday, Dec. 12, 2025, after opening near $168.36 and moving between $166.62 and $171.81 during the session, according to consolidated market data. The move caps a notable short-term rebound

12 December 2025

ACA Updates · Analyst Forecasts · Financial News · Healthcare · Stock Market

UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group Incorporated (NYSE: UNH) has been at the center of one of 2025’s biggest blue‑chip storylines: a brutal share-price collapse, a messy reset in Medicare Advantage, a Department of Justice (DOJ) probe, credit‑rating downgrades, and now a tentative turn

11 December 2025

Financial Analysis · Healthcare · Investing · Market Trends · Stock Market

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

New York / Hartford – December 10, 2025 – CVS Health Corporation (NYSE: CVS) is back in Wall Street’s good graces. After a bruising 2024, the stock has staged a powerful rebound in 2025 as management raised its 2025–2026 profit

10 December 2025

Artificial Intelligence · Business Strategy · Healthcare · Investment Analysis · NYSE:CVS · Stock Market

Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson stock (NYSE: JNJ) has quietly turned into one of 2025’s standout blue‑chip winners. As of December 9, 2025, JNJ trades around $202 per share, valuing the company at roughly $486 billion and leaving the stock up close

9 December 2025

Earnings Reports · Healthcare · Investing · NYSE:JNJ · Pharma Industry · Stock Market

GE HealthCare Technologies Inc (GEHC): AI Imaging Surge, Intelerad Deal and 2026 Stock Forecasts – Latest News as of December 7, 2025

Updated December 7, 2025 GE HealthCare Technologies Inc (Nasdaq: GEHC) is closing out 2025 with a flurry of announcements that signal an aggressive pivot toward AI-powered imaging, cloud software and long-term clinical alliances. From a $2.3 billion deal to acquire

7 December 2025

Artificial Intelligence · Healthcare · Medical Imaging · NASDAQ:GEHC · Stock Market · Technology News

Lyft Stock (LYFT) in December 2025: Healthcare Push, Profit Turnaround and What Wall Street Expects Next

Lyft stock is back on investors’ radar. As of December 7, 2025, shares of Lyft Inc. (NASDAQ: LYFT) trade around $22.97, near the upper end of their 52‑week range and up sharply this year, while analysts debate whether the ride‑hailing

7 December 2025

Financial Analysis · Healthcare · Investing · NASDAQ:LYFT · Stock Market · Wall Street

Healthcare News 7 December 2025 - 20 December 2025